Metabolomics: Implication in cardiovascular research and diseases

被引:1
|
作者
Ajoolabady, Amir [1 ]
Pratico, Domenico [2 ]
Dunn, Warwick B. [3 ,4 ]
Lip, Gregory Y. H. [5 ,6 ,7 ]
Ren, Jun [8 ,9 ]
机构
[1] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL USA
[2] Temple Univ, Alzheimers Ctr Temple, Lewis Katz Sch Med, Philadelphia, PA USA
[3] Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Biochem & Syst Biol, Liverpool, England
[4] Univ Birmingham, Inst Metab & Syst Res, Coll Med & Dent Sci, Birmingham, England
[5] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, England
[6] Liverpool Heart & Chest Hosp, Liverpool, England
[7] Aalborg Univ, Dept Clin Med, Aalborg, Denmark
[8] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Dept Cardiol, Shanghai, Peoples R China
[9] Natl Clin Res Ctr Intervent Med, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
cardiomyopathy; cardiovascular diseases; heart failure; metabolomics; SPECTROMETRY-BASED METABOLOMICS; MASS-SPECTROMETRY; SUBCLINICAL ATHEROSCLEROSIS; TARGETED METABOLOMICS; SERUM METABOLOMICS; FATTY-ACIDS; HEART; METABOLISM; RISK; BIOMARKERS;
D O I
10.1111/obr.13825
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cellular metabolism influences all aspects of cellular function and is crucial for overall organismal health. Metabolic disorders related to cardiovascular health can lead to cardiovascular diseases (CVDs). Moreover, associated comorbidities may also damage cardiovascular metabolism, exacerbating CVD and perpetuating a vicious cycle. Given the prominent role of metabolic alterations in CVD, metabolomics has emerged as an imperative technique enabling a comprehensive assessment of metabolites and metabolic architecture within the body. Metabolite profile and metabolic pathways help to deepen and broaden our understanding of complex genomic landscape and pathophysiology of CVD. Here in this review, we aim to overview the experimental and clinical applications of metabolomics in pathogenesis, diagnosis, prognosis, and management of various CVD plus future perspectives and limitations. Metabolomics is a powerful technique enabling comprehensive assessment of metabolites and metabolic architecture in the cardiovascular system. The application of metabolomics in experimental and clinical research in CVD may reveal novel insights into the pathogenesis, treatment, diagnosis, and prognosis of such diseases. Besides, newly identified metabolites by metabolomics and their role in cardiovascular research and diseases have been summarized.image
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Metabolomics in cardiovascular diseases
    Kordalewska, Marta
    Markuszewski, Michal J.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2015, 113 : 121 - 136
  • [2] Cardiovascular Metabolomics
    McGarrah, Robert W.
    Crown, Scott B.
    Zhang, Guo-Fang
    Shah, Svati H.
    Newgard, Christopher B.
    CIRCULATION RESEARCH, 2018, 122 (09) : 1238 - 1258
  • [3] Translating Metabolomics to Cardiovascular Biomarkers
    Senn, Todd
    Hazen, Stanley L.
    Tang, W. H. Wilson
    PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 55 (01) : 70 - 76
  • [4] Metabolomics in chronic lung diseases
    Nambiar, Shabarinath
    Bong How, Sze
    Gummer, Joel
    Trengove, Robert
    Moodley, Yuben
    RESPIROLOGY, 2020, 25 (02) : 139 - 148
  • [5] Metabolomics and Lipidomics for Studying Metabolic Syndrome: Insights into Cardiovascular Diseases, Type 1 & 2 Diabetes, and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Rakusanova, Stanislava
    Cajka, Tomas
    PHYSIOLOGICAL RESEARCH, 2024, 73 : S165 - S183
  • [6] MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker
    Huang, Ying
    Li, Jun
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2015, 71 (03) : 479 - 486
  • [7] Metabolomics through the lens of precision cardiovascular medicine
    Lam, Sin Man
    Wang, Yuan
    Li, Bowen
    Du, Jie
    Shui, Guanghou
    JOURNAL OF GENETICS AND GENOMICS, 2017, 44 (03) : 127 - 138
  • [8] Research Progress of Metabolomics in Asthma
    Wang, Chao
    Jiang, Shengyu
    Zhang, Siyu
    Ouyang, Zhuoer
    Wang, Guoqiang
    Wang, Fang
    METABOLITES, 2021, 11 (09)
  • [9] Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential
    Tunon, Jose
    Barbas, Coral
    Blanco-Colio, Luis
    Burillo, Elena
    Lorenzo, Oscar
    Luis Martin-Ventura, Jose
    Mas, Sebastian
    Javier Ruperez, Francisco
    Egido, Jesus
    EXPERT REVIEW OF PROTEOMICS, 2016, 13 (09) : 857 - 871
  • [10] Implication of Gut Microbiota in Cardiovascular Diseases
    Zhou, Wenyi
    Cheng, Yiyu
    Zhu, Ping
    Nasser, M., I
    Zhang, Xueyan
    Zhao, Mingyi
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020